-
Kunkemoeller B, Prendeville H, McIntyre C, Temesgen A, Loftus RM, Yao C, Dyck L, Sinclair LV, Rollings C, Douglas A, Pernes G, Mitchelson KAJ, Harmon C, Raverdeau M, Ward R, Kane H, Kline J, O'Brien KL, Brennan M, Smith F, Stevens B, Roche HM, Lavelle EC,
The source of dietary fat influences anti-tumour immunity in obese mice Nat Metab
-
Hinwood NS, Casey MB, Dunlevy CG, Doody C, Blake C, Fullen BM, O'Donoghue G, Birney S, Fildes F, Smart KM.
It Is a Vicious Circle: Experiences of People Living With Obesity and Chronic Pain: A Qualitative Evidence Synthesis (QES) Obes Rev
-
Smith L, López Sánchez GF, Veronese N, Soysal P, Tully MA, Kostev K, Butler L, Keyes H, Barnett Y, Shin JI, Koyanagi A.
Physical multimorbidity and dynapenic abdominal obesity among older adults from low- and middle-income countries Commun Med (Lond)
-
Coleman S, Lynch C, Worlikar H, Kelly E, Loveys K, Simpkin AJ, Walsh JC, Broadbent E, Finucane FM, O' Keeffe D.
Digital Clinicians Performing Obesity Medication Self-Injection Education: Feasibility Randomized Controlled Trial JMIR Diabetes
-
Pack A, Grunstein R, Mokhlesi B, Ryan S, Schwab R, Gozal D.
What will the impact be of use of tirzepatide in patients with obstructive sleep apnea (OSA)? Sleep
-
Parker CH, Slattery C, Brennan DJ, le Roux CW.
Glucagon-like peptide 1 (GLP-1) receptor agonists’ use during pregnancy: Safety data from regulatory clinical trials Diabetes Obes Metab
-
Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, Das S, Lee CJ, Glass LC, Senyucel C, Dunn JP; SURMOUNT-5 Trial Investigators.
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity N Engl J Med
-
Sherifali D, Racey M, Fitzpatrick-Lewis D, Greenway M, Sockalingam S, Wada J, Teoh SH, Patton I, Macklin D, van Rossum EFC, Busetto L, Horn DB, Patricia Nece JD, Leguede MEGS, Pearce N, Le Roux C, Ard J, Alberga AS, Kaplan L, Sharma AM, Wharton S.
Missing the Target: A Scoping Review of the Use of Percent Weight Loss for Obesity Management Obes Rev
-
Al-Najim W, Raposo A, BinMowyna MN, le Roux CW.
Unintended Consequences of Obesity Pharmacotherapy: A Nutritional Approach to Ensuring Better Patient Outcomes Nutrients
-
Almohaileb FI, le Roux CW, Crotty M.
Why do patients with obesity discontinue glucagon-like peptide 1 analogues? Diabetes Obes Metab